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Lactic acid bacteria were isolated from tungrymbai, a traditional fermented soybean product of Meghalaya, India 
and assessed for their probiotic properties. Survival under simulated gastric conditions was tested and fi ve acid 
tolerant strains were selected. By using 16S rDNA sequencing, these isolates were confi rmed to be Enterococcus 
species. The strains exhibited good survivability in high concentrations of bile salts. The strains were susceptible to 
antibiotics and they were also found to inhibit growth of Staphylococcus aureus and Escherichia coli. The strains 
were gelatinase negative and non-haemolytic. The strains also assimilated cholesterol up to a certain level. The study 
confi rmed that all identifi ed fi ve strains have in vitro probiotic properties.
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Soybean (Glycine max) is an important source of proteins. It is also popular for its high 
nutritional value viz. vitamin A, B, C, and minerals. The production of tungrymbai (fermented 
product prepared from soybean) is a traditional art carried out by the Khasi tribe of Meghalaya, 
India. The colour of the product is brown with a characteristic odour and mild pungency (DAS 
& DEKA, 2012). The Khasis enjoy this food because of the acquired taste and also due to the 
health benefi ts associated with its consumption (AGRAHAR-MURUGKAR & SUBBULAKSHMI, 
2006). The high crude protein content of fermented soy products may be attributed to the 
microbiota developed during fermentation of these products (GUPTA et al., 2007). The 
biological activity of fermented soybean foods is mainly due to isofl avones that exhibit 
estrogenic, antioxidative, antiosteoporotic, and anti-carcinogenic activities (SAMRUAN et al., 
2012). Lactic acid bacteria (LAB) are the most common and dominant microorganisms 
present in fermented foods. They are generally recognized as safe organisms (GRAS) to be 
used as probiotics (FULLER, 1989). Reports indicate that LAB and their fermented products 
are effective at enhancing innate and adaptive immunity, prevent gastric mucosal lesion 
development, alleviate allergies, and put up defence against intestinal pathogen infection. 
LAB have been reported to be useful as health adjuncts and are commonly added to food as 
the delivery mechanism (CHOU & WEIMER, 1999). Many health benefi ts are reported owing to 
the consumption of fermented foods and some of these health benefi ts correlate to the 
benefi cial effects brought about by the intake of microorganisms. Thus, investigation of 
probiotic organisms with new and potentially powerful tools will facilitate the development 
of the bacteria as therapeutic agents, and provide the mechanisms to produce advanced 
probiotic strains (CALLANAN, 2005). On the basis of the above scenarios, this study was aimed 
at isolating LAB from tungrymbai, to identify them and to test their probiotic properties. It is 
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expected that this study will further help in incorporation of these strains for the production 
of functional foods.
1. Materials and methods
1.1. Sampling and isolation of lactic acid bacteria
Samples of tungrymbai were collected from four different places of the state of Meghalaya, 
India. Lactobacillus plantarum ATCC 8014, Staphylococcus aureus MTCC 3160, and 
Escherichia coli MTCC 40 were provided by the Department of Food Engineering and 
Technology, Tezpur University. L. plantarum ATCC 8014 is considered to be a safe and 
benefi cial probiotic that allows its usage as a reference organism in this study (POP et al., 
2015). The chemicals (AR grade) and media used were obtained from Sigma-Aldrich 
Corporation, USA. LAB were isolated on MRS agar plates supplemented with bromocresol 
purple indicator for 48 h at 37 °C under anaerobic conditions. The cells were Gram-stained 
and observed in a trinocular microscope (DM 3000, Leica Microsystems, Germany). For 
catalase test, few drops of 3% H2O2 were pipetted over the growth on MRS slants. After 
purity controlling, cultures were maintained in MRS broth.
1.2. Identifi cation of isolates
The isolates were grown in MRS broth for 24 h at 37 °C and then pelleted by centrifugation. 
For the isolation and purifi cation of genomic DNA, a DNA purifi cation kit (K0512, 
ThermoScientifi c, EU) was used. Amplifi cation was carried out in a thermocycler 
(Mastercycler Nexus Gradient, Eppendorf, USA) using PCR master mix, DNA template, and 
the 16S rRNA universal primers set consisted of “27f” forward primer 
(5’-GAGAGTTTGATCCTGGCTCAG-3’) and “1495r” reverse primer 
(5’-CTACGGCTACCTTGTTACGA-3’). The conditions used were initial denaturation at 
95 °C for 3 min, followed by 30 cycles of 94 °C (1 min), 55 °C (1 min), 72 °C (1 min), linked 
to 72 °C (10 min), and then to 5 °C. Purifi cation of PCR product was done using a kit (K0701, 
Fermantas, EU). Electrophoresis of the purifi ed PCR products were performed on 0.6% 
agarose gel and the ethidium bromide stained PCR-amplifi ed bands were observed under UV 
illumination in the gel-doc system (MiniBIS Pro, DNR Bio-Imaging Systems, Israel). 
Amplifi ed DNA was sequenced using an automated DNA sequencer (Instrument 3500, 
Applied Biosystems) by chain termination method. The DNA sequences obtained were 
converted to their FASTA form and organisms were identifi ed by comparing each consensus 
sequences to a database library of known 16S rDNA using NCBI BLAST tool.
1.3. Simulation of gastric conditions and bile tolerance test
The growth of the isolates in simulated gastric conditions was performed by their growth in 
MRS broth with pH adjusted to 7, 3, and 2 with 5 N HCl (HASSANZADAZAR et al., 2012). The 
tolerance of strains towards bile salts was evaluated in MRS broth supplemented with 
different concentrations (0.3 to 15%) of bile salts (DORA & GLENN, 2002). In both cases, 100 
μl of actively growing 24 h culture of the strains were inoculated into 5 ml of the appropriate 
test media in test tubes and incubated for 24 h under anaerobic conditions at 37 °C. After the 
end of incubation period, the viable cells were enumerated by pour plate counts on MRS agar 
plates after 10-fold serial dilutions prepared in 0.1% peptone water.
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1.4.  In vitro cholesterol lowering property and gelatine hydrolysis and haemolysis activity 
tests
The strains were grown in MRS broth containing 0.4% bile salt and 0.01% polyoxyethylene-
cholesteryl sebacate. The amount of cholesterol removed was calculated according to Eq. 1.
        residual cholesterol in cell free broth
% Cholesterol removed= 1 – _______________________________  × 100                      (1)
cholesterol of control broth
Cholesterol assimilated was expressed as the amount of cholesterol consumed in mg g–1 
of cells. Total cholesterol was analysed using the method of ATTARDE and co-workers (2010). 
Gelatinase activity was tested by the method of HARRIGAN and MCCANCE (1990) and 
haemolysis activity was investigated as described by GERHARDT and co-workers (1981). 
A strain of S. aureus was used as positive control.
1.5. Antibiotic susceptibility test and detection of antimicrobial activity
Sensitivity of the isolates to antibiotics was tested using different antibiotic discs on Antibiotic 
Susceptibility Test Media No. 2 (HiMedia, India) plated on 150 mm diameter Petri plates. 
The media were overlaid with the diluted cultures (1–2×108 CFU ml–1) of the test organism 
and the antibiotic discs were placed upon the inoculated agar surface. Incubation was done at 
37 °C under anaerobic conditions for 24 h. The zones of inhibition were measured using an 
antibiotic zone scale to the nearest millimetre. The diameters of the zones are related to the 
susceptibility of the isolate and to the diffusion rate of the antibiotic through the agar medium 
(BAUER et al., 1966). Antimicrobial activity of the isolates was studied by agar spot test 
(SCHILLINGER & LUCKE, 1989). The indicator strains were E. coli MTCC 40 and S. aureus 
MTCC 3160. The antimicrobial activity was evaluated by zone of inhibition and expressed 
in mm.
2. Results and discussion
2.1. Screening for growth under simulated gastric conditions (acid tolerance)
Acid tolerance is one of the fi rst properties screened while selecting probiotic strains, since 
the most important and desirable property of probiotic bacteria is their ability to remain 
viable under acidic conditions of the gastrointestinal tract (TUOMOLA et al., 2001). All isolates 
were tested for their survivability under pH 2, 3, and 7 for 24 h at 37 ºC. From all fi ve 
samples, the most tolerant strains were selected and their results are shown in Table 1. All the 
isolates except BASTU2 had counts above 6 log CFU at pH 7 and all of them survived at pH 
3. BASTU3, BASTU4, and BASTU5 showed higher level of tolerance by surviving at pH 2 
and showed counts of 5.57, 4.00, and 4.30 log CFU ml–1, respectively. On the other hand, L. 
plantarum ATCC 8014 showed count of 6.87 log CFU ml–1 at pH 3 and 7.67 log CFU ml–1 at 
pH 7.
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Table 1. Effect of pH on survivability
Strain name Count in log CFU ml–1
pH7 pH3 pH2
Enterococcus faecium BASTU1 6.96 4.00 0
Enterococcus faecium BASTU2 4.53 4.48 0
Enterococcus faecium BASTU3 7.57 6.00 5.57
Enterococcus lactis BASTU4 7.51 5.85 4.00
Enterococcus faecium BASTU5 7.47 5.86 4.30
Lactobacillus plantarum ATCC8014 7.62 5.49 4.11
2.2. Identifi cation of bacterial strains
The total counts of LAB isolated from soya product ranged from 8.98 to 9.02 log CFU g–1 in 
all collected samples. All fi ve isolates were found to be Gram-positive and catalase negative, 
which are indicative traits of the LAB group. The isolates BASTU1, BASTU2, BASTU3, 
BASTU4, and BASTU5 were identifi ed to belong to the species E. faecium, E. faecium, E. 
faecium, E. lactis, and E. faecium, respectively, and the NCBI accession numbers obtained 
for these identifi ed strains were KJ690925, KJ690923, KJ690924, KJ857034, and KJ857035, 
respectively. Enterococci belong to the LAB and are of specifi c importance in foods due to 
their involvement in the utilization as probiotics. E. faecium and E. faecalis strains are used 
as probiotics and are consumed in high numbers in the form of pharmaceutical preparations. 
In humans, these enterococcal probiotics are administered to treat diarrhoea, antibiotic-
associated diarrhoea, irritable bowel syndrome, to lower cholesterol levels, or to improve 
host immunity. Till date, there have been no reports of disease caused by enterococcal 
probiotics that are currently on the market. Moreover, some of these strains, such as E. 
faecium SF68 and E. faecalis Symbiofl or, were investigated for their safety and are available 
in the market for more than 20 years without any reported problems (FRANZ et al., 2011).
Along with other bacteria that are part of the normal fl ora, E. faecalis prevents the 
colonization of pathogenic bacteria in the body of its host by competing with the pathogens 
for binding sites and nutrients. It also enhances the immune system by inducing the production 
of low levels of antibodies against its own components, which, in turn, makes the immune 
system more effi cient. These characteristics of E. faecalis can also be used for the production 
of probiotic products, which are dietary supplements and foods that help to treat conditions 
such as infectious diarrhoea, IBS, and tooth decay. E. faecalis produces bacteriocin 
(a substance of proteinaceous character with inhibitory activity) that prevents the growth of 
several other bacteria, such as Listeria monocytogenes, Staphylococcus aureus, and Vibrio 
cholerae, thereby preventing the spoilage of dairy products (LIVESTRONG, 2013).
2.3.  Growth at different bile salts concentrations, cholesterol assimilation, gelatinase and 
haemolytic activity
Bile stability is a very important criterion of an effective probiotic bacterium. The probiotic 
microorganisms taken orally have to defend against the bile salt in the gastrointestinal tract, 
the strong acid medium in the stomach, since it must transit through the stomach and small 
intestine in order to colonize the human gastrointestinal tract (GUNN, 2000; TUOMOLA et al., 
2001). The results of bile salts concentration’s effect on the survivability of the isolated 
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Enterococcus species are shown in Table 2. It was found that E. faecium BASTU3, E. lactis 
BASTU4, and E. faecium BASTU5 showed highest survivability till 15% of bile salt 
concentration with plate count of 7.39 log CFU ml–1, 7.40 log CFU ml–1 and 
7.11 log CFU ml–1, respectively. E. faecium BASTU-2 survived till 4% showing plate count 
of 7.32 log CFU ml–1, E. faecium BASTU1 survived till 3.5% with plate count of 6.93 log 
CFU ml–1. L. plantarum ATCC 8014 on the other hand showed count of 6.69 log CFU ml–1 at 
15% bile salt concentration. REHAIEM and co-workers (2014) also reported the probiotic 
properties of E. faecium MMRA and observed no decrease in the viable count (in 0.3% bile 
salt) up to 300 min of incubation.
Table 2. Bile tolerance test
Strain Count in log CFU ml–1 at different concentrations (%) of bile salt
Con-
trol
0.3 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 6.0 8.0 10.0 15.0
E. faecium 
BASTU1
2.02 2.01 2.01 1.99 1.99 1.99 1.98 1.96 1.93 0 0 0 0 0
E. faecium 
BASTU2
2.09 2.08 2.06 2.04 2.03 2.01 1.99 1.96 1.91 1.90 0 0 0 0
E. faecium 
BASTU3
1.64 1.63 1.61 1.60 1.60 1.59 1.58 1.57 1.55 1.54 1.53 1.50 1.49 1.49
E. lactis 
BASTU4
1.64 1.63 1.63 1.62 1.61 1.61 1.60 1.60 1.59 1.58 1.57 1.56 1.55 1.54
E. faecium 
BASTU5
1.57 1.54 1.52 1.50 1.48 1.44 0.65 0.57 0.47 0.47 0.46 0.45 0.44 0.43
L. plantarum 
ATCC 8014
2.29 2.21 2.15 2.08 2.02 1.97 1.93 1.86 1.84 1.77 1.75 1.71 1.68 1.33
High level of serum cholesterol is associated with the risk of cardiovascular diseases 
and probiotic bacteria have demonstrated potential to lower cholesterol levels by different 
mechanisms, including cholesterol assimilation. Therefore, use of probiotic bacteria for 
reducing cholesterol has grabbed much attention (RAGHAVAN et al., 2011; TOMARO-DUCHESNEAU 
et al., 2014). E. lactis BASTU4 and E. faecium BASTU5 reduced the highest % of cholesterol 
(Table 3). Cholesterol assimilation ranged from 16.21 to 29.19 mg of cholesterol per g of 
cells and the highest value was recorded for E. faecium BASTU5 (Table 3). DORA and GLENN 
(2002) studied E. faecalis strains isolated from the human gut and found that the strains 
assimilated more than 1.5 times the average of the other strains in the media with 0.2 and 
0.4% (w/v) ox gall. All the Enterococcus isolates, including L. plantarum ATCC 8014, 
showed negative gelatinase and haemolysis (γ-haemolytic) activity. Absence of gelatinase 
activity and haemolytic activity are selection criteria for probiotic strains, indicating that 
these bacteria are non-virulent (DE VUYST et al., 2003).
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Table 3. Cholesterol assimilation test
Strain Reduction in cholesterol content (%) Cholesterol assimilated (mg g–1)
E. faecium BASTU1 52.13 16.21
E. faecium BASTU2 61.16 19.46
E. faecium BASTU3 74.88 24.18
E. lactis BASTU4 76.13 26.24
E. faecium BASTU5 84.16 29.19
L. plantarum ATCC 8014 88.52 33.15
2.4. Antibiotic susceptibility
Antibiotic susceptibility of isolates is a crucial criterion from the safety point of view of 
potential probiotics. The results for antibiotic susceptibility test are presented in Table 4 and 
all strains were susceptible to the tested antibiotics. E. faecium BASTU1 showed less 
susceptibility (10 mm to 16 mm) against the antibiotics sulphatriad, bacitracin, polymyxin B, 
gentamicin, neomycin, and streptomycin. However, its susceptibility remained in the range 
of 21 mm to 29 mm for the other antibiotics and similar pattern was also shown by E. faecium 
BASTU2. E. faecium BASTU3 was found to be less susceptible against the antibiotics 
bacitracin, polymyxin B, gentamicin, neomycin, streptomycin, and sulphatriad as compared 
to the other antibiotics. E. lactis BASTU4 and E. faecium BASTU5 showed total susceptibility 
in similar pattern, and L. plantarum ATCC 8014 showed high susceptibility in the range of 
11–35 mm. Specifi c antibiotic resistance determinants carried on mobile genetic elements are 
often detected in the typical probiotic genera, thus representing a safety issue. However, 
when mutations or intrinsic resistance mechanisms are responsible for the resistance 
phenotype, the antibiotic resistance in these organisms does not constitute a safety concern in 
itself (GUEIMONDE et al., 2013)
Table 4. Antibiotic susceptibility test













Bacitracin – 10 units 13 15 16 19 26 28
Chloramphenicol 
–30 μg
27 30 27 27 24 31
Penicillin G – 10 units 21 25 23 24 18 29
Polymyxin B -300 μg 12 15 14 10 16 22
Gentamicin – 10 μg 16 18 17 17 17 25
Neomycin – 30 μg 11 13 11 11 13 20
Ampicillin – 10 μg 29 28 29 31 32 35
Streptomycin – 10 μg 14 17 15 18 18 21
Sulphatriad – 300 μg 10 10 10 10 10 11
Tetracycline – 25 μg 29 31 33 34 33 35
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2.5. Antimicrobial activity of the isolates
Good probiotics should present their antimicrobial actions particularly to the pathogens in the 
GI system. All the studied Enterococcus strains were highly effective towards both the tested 
pathogenic bacteria, i.e., S. aureus and E. coli (Table 5). S. aureus is a major opportunistic 
human pathogen both in hospital and the community. Considerable research efforts have also 
been put to understand its complex pathogenesis (RASIGADE & VANDENESCH, 2014)
Table 5. Antimicrobial activity test
Strain Zone of inhibition (mm)*
S. aureus E. coli
E. faecium BASTU1 18.33±1.53 26.00±1.00
E. faecium BASTU2 19.33±1.53 25.33±1.53
E. faecium BASTU3 19.00±2.00 25.67±0.58
E. lactis BASTU4 19.00±1.00 25.00±1.00
E. faecium BASTU5 20.00±1.00 26.33±1.15
L. plantarum ATCC 8014 21.00±1.00 28.00±1.00
      * (n=3)±SD
Even though E. coli can be an innocuous resident of the gastrointestinal tract, pathogenic 
variants of E. coli are a major public health concern as they have low infectious doses and are 
transmitted through ubiquitous mediums like food and water. They can cause a broad range 
of human diseases, such as infections in the gastrointestinal tract, urinary tract, bloodstream, 
and central nervous system (CROXEN et al., 2013). Highest activity against S. aureus was 
shown by E. faecium BASTU5, also E. faecium BASTU2, E. faecium BASTU3, and E. lactis 
BASTU4 exhibited good activity. In case of E. coli, the zones of inhibition were relatively 
larger than for S. aureus. Both E. faecium BASTU1 and E. faecium BASTU5 showed higher 
activity against E. coli than the other strains.
3. Conclusions
Phenotypic and genotypic identifi cation confi rmed that all fi ve isolates from tungrymbai of 
Meghalaya, India were Enterococcus spp. The results of the present investigation support the 
importance of this fermented food. Further investigation, particularly at the molecular level, 
will help to consider these strains as the potential candidates for inclusion as starter cultures 
in fermentation processes and also to reveal their probiotic properties. Moreover, additional 
studies at the molecular level must ascertain that these strains follow EFSA rules and also to 
eliminate any gene of virulence factors if present. The future studies will certainly be 
benefi cial to consumers by quantitatively confi rming health benefi ts and also to manufactures 
by providing more information on the stability of the strains .
*
The authors are thankful to the Khasi community of Meghalaya, India for sharing their knowledge on the 
methodology of tungrymbai preparation.
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